These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3501545)

  • 1. Pharmacokinetics of leucovorin (D,L-5-formyltetrahydrofolate) after intravenous injection and constant intravenous infusion.
    Straw JA; Newman EM; Doroshow JH
    NCI Monogr; 1987; (5):41-5. PubMed ID: 3501545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of the diastereoisomers of leucovorin after intravenous and oral administration to normal subjects.
    Straw JA; Szapary D; Wynn WT
    Cancer Res; 1984 Jul; 44(7):3114-9. PubMed ID: 6609768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacokinetics of high-dose leucovorin calcium after intravenous and oral administration.
    Schilsky RL; Ratain MJ
    J Natl Cancer Inst; 1990 Sep; 82(17):1411-5. PubMed ID: 2388292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic analysis of (6S)-5-formyltetrahydrofolate (1-CF), (6R)-5-formyltetrahydrofolate (d-CF) and 5-methyltetrahydrofolate (5-CH3-THF) in patients receiving constant i.v. infusion of high-dose (6R,S)-5-formyltetrahydrofolate (leucovorin).
    Straw JA; Newman EM
    Adv Exp Med Biol; 1988; 244():53-8. PubMed ID: 3266829
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetics of reduced folates after short-term infusion of d, 1-folinic acid.
    Schalhorn A; Kühl M; Stupp-Poutot G; Nüssler V
    Cancer Chemother Pharmacol; 1990; 25(6):440-4. PubMed ID: 2311173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacokinetics of fluorouracil and folinic acid.
    Schalhorn A; Kühl M
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):82-92. PubMed ID: 1557660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between dose rate of [6RS]Leucovorin administration, plasma concentrations of reduced folates, and pools of 5,10-methylenetetrahydrofolates and tetrahydrofolates in human colon adenocarcinoma xenografts.
    Houghton JA; Williams LG; de Graaf SS; Cheshire PJ; Rodman JH; Maneval DC; Wainer IW; Jadaud P; Houghton PJ
    Cancer Res; 1990 Jun; 50(12):3493-502. PubMed ID: 2140289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absorption kinetics of orally administered leucovorin calcium.
    McGuire BW; Sia LL; Haynes JD; Kisicki JC; Gutierrez ML; Stokstad EL
    NCI Monogr; 1987; (5):47-56. PubMed ID: 3501546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of leucovorin metabolites in human plasma as a function of dose administered orally and intravenously.
    Priest DG; Schmitz JC; Bunni MA; Stuart RK
    J Natl Cancer Inst; 1991 Dec; 83(24):1806-12. PubMed ID: 1744924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma and tumor tissue pharmacology of high-dose intravenous leucovorin calcium in combination with fluorouracil in patients with advanced colorectal carcinoma.
    Trave F; Rustum YM; Petrelli NJ; Herrera L; Mittelman A; Frank C; Creaven PJ
    J Clin Oncol; 1988 Jul; 6(7):1184-91. PubMed ID: 3260621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacology of the stereoisomers of leucovorin during repeated oral dosing.
    Schilsky RL; Choi KE; Vokes EE; Guaspari A; Guarnieri C; Whaling S; Liebner MA
    Cancer; 1989 Mar; 63(6 Suppl):1018-21. PubMed ID: 2783878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of rac-leucovorin vs [S]-leucovorin in patients with advanced gastrointestinal cancer.
    Mader RM; Steger GG; Rizovski B; Sieder AE; Locker G; Gnant MF; Jakesz R; Rainer H
    Br J Clin Pharmacol; 1994 Mar; 37(3):243-8. PubMed ID: 8198932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of diastereoisomers of (6R,S)-folinic acid (leucovorin) in humans during constant high-dose intravenous infusion.
    Newman EM; Straw JA; Doroshow JH
    Cancer Res; 1989 Oct; 49(20):5755-60. PubMed ID: 2676149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic comparison of leucovorin and levoleucovorin.
    Zittoun J; Tonelli AP; Marquet J; De Gialluly E; Hancock C; Yacobi A; Johnson JB
    Eur J Clin Pharmacol; 1993; 44(6):569-73. PubMed ID: 8405015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in the pharmacokinetics of the diastereoisomers of citrovorum factor in dogs.
    Straw JA; Covey JM; Szapary D
    Cancer Res; 1981 Oct; 41(10):3936-9. PubMed ID: 6974592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioequivalence of oral and injectable levoleucovorin and leucovorin.
    DeVito JM; Kozloski GD; Tonelli AP; Johnson JB
    Clin Pharm; 1993 Apr; 12(4):293-9. PubMed ID: 8458180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of leucovorin calcium after intravenous, intramuscular, and oral administration.
    McGuire BW; Sia LL; Leese PT; Gutierrez ML; Stokstad EL
    Clin Pharm; 1988 Jan; 7(1):52-8. PubMed ID: 3257913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of dose of [6RS]leucovorin on reduced folate pools and 5-fluorouracil-mediated thymidylate synthase inhibition in human colon adenocarcinoma xenografts.
    Houghton JA; Williams LG; Cheshire PJ; Wainer IW; Jadaud P; Houghton PJ
    Cancer Res; 1990 Jul; 50(13):3940-6. PubMed ID: 2354443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioequivalence of two leucovorin calcium tablet formulations.
    De Vito JM; McGuire BW; De Lap RJ; Weiss AI
    DICP; 1989 Feb; 23(2):153-4. PubMed ID: 2786292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Plasma kinetic study following oral administration of leucovorin tablets in patients with gastric cancer--influence of subtotal gastrectomy].
    Nashimoto A; Sasaki J; Akai S; Sato T; Inada S
    Gan To Kagaku Ryoho; 1989 Dec; 16(12):3747-54. PubMed ID: 2596859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.